 Isabelle Buard
Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 7 | 2023 | 334 | 3.630 |
Why?
| | Transcranial Magnetic Stimulation | 4 | 2020 | 43 | 2.070 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 301 | 1.390 |
Why?
| | Magnetoencephalography | 3 | 2021 | 103 | 1.170 |
Why?
| | Neuroglia | 4 | 2014 | 157 | 0.930 |
Why?
| | Synapses | 5 | 2014 | 344 | 0.850 |
Why?
| | Tremor | 1 | 2022 | 46 | 0.850 |
Why?
| | Purkinje Cells | 2 | 2014 | 65 | 0.820 |
Why?
| | Brain Waves | 1 | 2021 | 22 | 0.820 |
Why?
| | Agnosia | 1 | 2021 | 2 | 0.810 |
Why?
| | Motor Disorders | 1 | 2021 | 16 | 0.800 |
Why?
| | Music Therapy | 1 | 2021 | 21 | 0.800 |
Why?
| | Parietal Lobe | 1 | 2021 | 42 | 0.790 |
Why?
| | Connectome | 1 | 2021 | 63 | 0.780 |
Why?
| | Temporal Lobe | 1 | 2021 | 90 | 0.770 |
Why?
| | Travel-Related Illness | 1 | 2020 | 5 | 0.760 |
Why?
| | Disabled Persons | 1 | 2021 | 147 | 0.680 |
Why?
| | Nerve Net | 1 | 2021 | 232 | 0.650 |
Why?
| | Neurons | 5 | 2014 | 1345 | 0.580 |
Why?
| | Psychomotor Performance | 1 | 2019 | 290 | 0.580 |
Why?
| | Alzheimer Disease | 1 | 2021 | 513 | 0.530 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2014 | 159 | 0.510 |
Why?
| | Cerebellum | 2 | 2014 | 203 | 0.510 |
Why?
| | Disease Progression | 1 | 2021 | 2490 | 0.500 |
Why?
| | Cognition Disorders | 1 | 2017 | 529 | 0.450 |
Why?
| | Basal Ganglia | 2 | 2023 | 44 | 0.390 |
Why?
| | Proteins | 2 | 2014 | 938 | 0.380 |
Why?
| | Dendrites | 1 | 2010 | 88 | 0.350 |
Why?
| | Long-Term Potentiation | 1 | 2010 | 148 | 0.330 |
Why?
| | Memory | 1 | 2010 | 230 | 0.330 |
Why?
| | Brain Mapping | 3 | 2021 | 532 | 0.320 |
Why?
| | Patch-Clamp Techniques | 3 | 2014 | 247 | 0.290 |
Why?
| | Magnetic Resonance Imaging | 4 | 2023 | 3174 | 0.270 |
Why?
| | Hippocampus | 3 | 2023 | 735 | 0.250 |
Why?
| | Atrophy | 1 | 2023 | 164 | 0.210 |
Why?
| | Fingers | 1 | 2022 | 83 | 0.210 |
Why?
| | Coculture Techniques | 2 | 2014 | 208 | 0.210 |
Why?
| | Mice, Inbred BALB C | 4 | 2014 | 1206 | 0.210 |
Why?
| | Motor Skills | 1 | 2022 | 85 | 0.200 |
Why?
| | Electric Stimulation | 2 | 2014 | 268 | 0.200 |
Why?
| | Parkinsonian Disorders | 1 | 2021 | 29 | 0.200 |
Why?
| | Humans | 13 | 2023 | 118969 | 0.200 |
Why?
| | Animals, Newborn | 3 | 2014 | 806 | 0.200 |
Why?
| | Microtubule-Associated Proteins | 2 | 2014 | 188 | 0.190 |
Why?
| | Acoustic Stimulation | 2 | 2019 | 321 | 0.190 |
Why?
| | Periodicity | 1 | 2019 | 56 | 0.180 |
Why?
| | Neuroimaging | 1 | 2021 | 256 | 0.170 |
Why?
| | Gait | 1 | 2021 | 253 | 0.170 |
Why?
| | Neuropsychological Tests | 1 | 2023 | 1032 | 0.160 |
Why?
| | Neural Pathways | 1 | 2018 | 277 | 0.150 |
Why?
| | Vision Disorders | 1 | 2018 | 135 | 0.150 |
Why?
| | Cholesterol | 3 | 2014 | 373 | 0.140 |
Why?
| | Calmodulin | 2 | 2014 | 73 | 0.140 |
Why?
| | Cues | 1 | 2018 | 297 | 0.140 |
Why?
| | Central Nervous System Diseases | 1 | 2017 | 64 | 0.140 |
Why?
| | Calcium | 2 | 2014 | 1169 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1244 | 0.140 |
Why?
| | Excitatory Postsynaptic Potentials | 3 | 2014 | 105 | 0.140 |
Why?
| | Cells, Cultured | 3 | 2014 | 4077 | 0.130 |
Why?
| | Male | 7 | 2021 | 57800 | 0.130 |
Why?
| | Action Potentials | 2 | 2014 | 420 | 0.120 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2014 | 32 | 0.120 |
Why?
| | Models, Biological | 1 | 2021 | 1715 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2014 | 404 | 0.120 |
Why?
| | Biophysics | 1 | 2014 | 73 | 0.120 |
Why?
| | Patient Safety | 1 | 2017 | 281 | 0.120 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6561 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1515 | 0.110 |
Why?
| | Culture Media, Conditioned | 2 | 2010 | 112 | 0.110 |
Why?
| | Mice | 5 | 2014 | 15520 | 0.110 |
Why?
| | Phosphorylation | 3 | 2014 | 1633 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2019 | 3171 | 0.100 |
Why?
| | Cognition | 1 | 2018 | 1024 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4552 | 0.100 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 20 | 0.090 |
Why?
| | Benzylamines | 1 | 2010 | 40 | 0.090 |
Why?
| | Thy-1 Antigens | 1 | 2010 | 11 | 0.090 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 18 | 0.090 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2010 | 32 | 0.090 |
Why?
| | Animals | 8 | 2014 | 33381 | 0.090 |
Why?
| | Rats | 4 | 2014 | 5392 | 0.090 |
Why?
| | Conditioning, Classical | 1 | 2010 | 89 | 0.090 |
Why?
| | Glutamate Decarboxylase | 1 | 2010 | 159 | 0.090 |
Why?
| | Neural Inhibition | 1 | 2010 | 160 | 0.090 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2025 | 0.080 |
Why?
| | Aged | 3 | 2021 | 19656 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1094 | 0.080 |
Why?
| | Adult | 2 | 2020 | 31510 | 0.080 |
Why?
| | Macular Degeneration | 1 | 2009 | 151 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 653 | 0.080 |
Why?
| | Retina | 1 | 2009 | 278 | 0.070 |
Why?
| | Female | 4 | 2021 | 61564 | 0.070 |
Why?
| | Behavior, Animal | 1 | 2010 | 486 | 0.070 |
Why?
| | Sulfonamides | 1 | 2010 | 445 | 0.070 |
Why?
| | Middle Aged | 3 | 2021 | 27617 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2020 | 9342 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2010 | 702 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2010 | 726 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 1945 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2478 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 811 | 0.060 |
Why?
| | Behavior | 1 | 2018 | 95 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2445 | 0.040 |
Why?
| | Child | 1 | 2017 | 19129 | 0.040 |
Why?
| | Computational Biology | 1 | 2021 | 588 | 0.040 |
Why?
| | Protein Binding | 2 | 2014 | 1975 | 0.040 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2014 | 9 | 0.030 |
Why?
| | Brain | 1 | 2006 | 2490 | 0.030 |
Why?
| | Algorithms | 1 | 2021 | 1541 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2014 | 270 | 0.030 |
Why?
| | Point Mutation | 1 | 2014 | 228 | 0.030 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 191 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 395 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2014 | 300 | 0.030 |
Why?
| | RNA Interference | 1 | 2014 | 460 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2014 | 828 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 564 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2014 | 408 | 0.030 |
Why?
| | PC12 Cells | 1 | 2010 | 40 | 0.020 |
Why?
| | Niemann-Pick Disease, Type C | 1 | 2009 | 2 | 0.020 |
Why?
| | Electroretinography | 1 | 2009 | 41 | 0.020 |
Why?
| | Nerve Degeneration | 1 | 2009 | 44 | 0.020 |
Why?
| | Phagosomes | 1 | 2009 | 43 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2010 | 371 | 0.020 |
Why?
| | Filipin | 1 | 2007 | 3 | 0.020 |
Why?
| | Heme Oxygenase (Decyclizing) | 1 | 2007 | 20 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 439 | 0.020 |
Why?
| | Electrophysiology | 1 | 2007 | 204 | 0.020 |
Why?
| | Retinal Ganglion Cells | 1 | 2007 | 92 | 0.020 |
Why?
| | Kinetics | 1 | 2010 | 1624 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2007 | 133 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2007 | 399 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2007 | 217 | 0.020 |
Why?
| | Autophagy | 1 | 2009 | 315 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 982 | 0.020 |
Why?
| | Blotting, Western | 1 | 2007 | 1194 | 0.020 |
Why?
| | Peptides | 1 | 2010 | 879 | 0.020 |
Why?
| | Fatty Acids | 1 | 2007 | 407 | 0.020 |
Why?
| | Cell Line | 1 | 2010 | 2707 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2009 | 2680 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1691 | 0.010 |
Why?
| | RNA | 1 | 2007 | 833 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2007 | 1753 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2006 | 2275 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2007 | 1510 | 0.010 |
Why?
| | Signal Transduction | 1 | 2010 | 4709 | 0.010 |
Why?
|
|
Buard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|